Senior Leadership

The Senior Leadership at Genmab comprises our CEO, a scientist with a deep understanding of the antibody field and proven business acumen, our CFO, who has more than 25 years of finance experience in the life sciences sector, our CDO, with more than 10 years of experience in R&D leadership roles in big pharma and six Senior Vice Presidents.  

Jan G. J. van de Winkel, Ph.D.Jan G. J. van de Winkel, Ph.D.

Dutch
President & Chief Executive Officer

David EwatwellDavid A. Eatwell

British (USA citizenship)
Executive Vice President & Chief Financial Officer

Judith-Klimovsky_190x100pxJudith Klimovsky, MD

American
Executive Vice President & Chief Development Officer  

Paul ParrenPaul W.H.I. Parren, Ph.D.

Dutch
Senior Vice President & Scientific Director

Birgitte StephensenBirgitte Stephensen, M.Sc.

Danish
Senior Vice President, IPR & Legal

bauer-michael-190x110pxMichael K. Bauer, Ph.D.

German
Senior Vice President, Clinical Development

Rachel Curtis GravesenRachel Curtis Gravesen

British
Senior Vice President, Investor Relations and Communications

Anthony PaganoAnthony Pagano

American
Senior Vice President, Global Finance

Martine van VugtMartine J. van Vugt, Ph.D.

Dutch
Senior Vice President Strategic Initiatives

Tahi-Ahmadi-in-CPH 190x110pxTahamtan Ahmadi, M.D., Ph.D.

Iranian-German (US Citizen)
Senior Vice President Oncology and Translational Medicine